Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BENCHMARK ELECTRONICS INC Regulatory Filings 2020

Dec 7, 2020

31997_rns_2020-12-08_cdc72831-5989-48ac-bdce-f7bd80278f58.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):December 2, 2020

BENCHMARK ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

Texas1-1056074-2211011

(State or other jurisdiction(Commission(I.R.S. Employer

of incorporation)File Number)Identification No.)

56 South Rockford Drive,Tempe,Arizona85281

(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code:(623)300-7000

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, par value $0.10 per shareBHENew York Stock Exchange, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On December 2, 2020, the Board of Directors of Benchmark Electronics, Inc. (the “Company”) adopted ministerial amendments (the “Amendments”) to the Company’s Amended and Restated Bylaws, effective immediately. The Amendments provide a more clear classification and delineation of elected senior officers of the Company. Article 4, Sections 1 and 8, and Article 5, Section 1 of the Amended & Restated Bylaws have been revised to adopt three classes of Vice Presidents: (i) Executive Vice Presidents, who are appointed by the Board of Directors and are incumbent to serve in the President and Chief Executive Officer’s (the “CEO”) absence, (ii) Senior Vice Presidents, who are appointed by the Board of Directors and serve as senior executive officers of the Company on the CEO’s direct staff, and (iii) Vice Presidents, who are subordinate to the aforementioned categories of senior officers described above.

The foregoing summary of the Amendments is qualified in its entirety by reference to the complete text of the new Amended & Restated Bylaws, a copy which is attached to this Current Report on Form 8-K as Exhibit 3.2.

I’Item 9.01 Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No.Description of Exhibit

3.2Amended & Restated Bylaws of Benchmark Electronics, Inc. dated December 2, 2020

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BENCHMARK ELECTRONICS, INC.

Date: December 7, 2020By: /s/ Stephen J. Beaver Stephen J. Beaver, Esq.
Vice President General Counsel

2